Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert L Sheffer

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
The Journal of Allergy and Clinical Immunology|September 4, 2007
Hereditary angioedema: Safety of long-term stanozolol therapyDavid E Sloane, Chyh Woei Lee, Albert L Sheffer
Current Allergy and Asthma Reports|January 25, 2003
Exercise-induced AnaphylaxisMariana C Castells, Richard F Horan, Albert L Sheffer
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|April 1, 2006
Safety and tolerability of inhaled budesonide in children in the Steroid Treatment As Regular Therapy in early asthma (START) trialMichael Silverman, Albert L Sheffer, Patricia V Díaz, et al.
BMC Gastroenterology|April 10, 2014
Abdominal attacks and treatment in hereditary angioedema with C1-inhibitor deficiencyEitan Rubinstein, Leslie E Stolz, Albert L Sheffer, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 4, 2013
Outcomes after ecallantide treatment of laryngeal hereditary angioedema attacksAlbert L Sheffer, Andrew J MacGinnitie, Marilyn Campion, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 11, 2005
Long-term safety of once-daily budesonide in patients with early-onset mild persistent asthma: results of the Inhaled Steroid Treatment as Regular Therapy in Early Asthma (START) studyAlbert L Sheffer, Mike Silverman, Ann J Woolcock, et al.
The Journal of Allergy and Clinical Immunology|April 13, 2011
Ecallantide (DX-88) for acute hereditary angioedema attacks: integrated analysis of 2 double-blind, phase 3 studiesAlbert L Sheffer, Marilyn Campion, Robyn J Levy, et al.
The New England Journal of Medicine|September 8, 2010
Ecallantide for the treatment of acute attacks in hereditary angioedemaMarco Cicardi, Robyn J Levy, Donald L McNeil, et al.
The Journal of Allergy and Clinical Immunology|August 10, 2010
The diagnosis and management of anaphylaxis practice parameter: 2010 updatePhillip Lieberman, Richard A Nicklas, John Oppenheimer, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
The Journal of Allergy and Clinical Immunology|September 4, 2007
Hereditary angioedema: Safety of long-term stanozolol therapyDavid E Sloane, Chyh Woei Lee, Albert L Sheffer
Current Allergy and Asthma Reports|January 25, 2003
Exercise-induced AnaphylaxisMariana C Castells, Richard F Horan, Albert L Sheffer
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|April 1, 2006
Safety and tolerability of inhaled budesonide in children in the Steroid Treatment As Regular Therapy in early asthma (START) trialMichael Silverman, Albert L Sheffer, Patricia V Díaz, et al.
BMC Gastroenterology|April 10, 2014
Abdominal attacks and treatment in hereditary angioedema with C1-inhibitor deficiencyEitan Rubinstein, Leslie E Stolz, Albert L Sheffer, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 4, 2013
Outcomes after ecallantide treatment of laryngeal hereditary angioedema attacksAlbert L Sheffer, Andrew J MacGinnitie, Marilyn Campion, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 11, 2005
Long-term safety of once-daily budesonide in patients with early-onset mild persistent asthma: results of the Inhaled Steroid Treatment as Regular Therapy in Early Asthma (START) studyAlbert L Sheffer, Mike Silverman, Ann J Woolcock, et al.
The Journal of Allergy and Clinical Immunology|April 13, 2011
Ecallantide (DX-88) for acute hereditary angioedema attacks: integrated analysis of 2 double-blind, phase 3 studiesAlbert L Sheffer, Marilyn Campion, Robyn J Levy, et al.
The New England Journal of Medicine|September 8, 2010
Ecallantide for the treatment of acute attacks in hereditary angioedemaMarco Cicardi, Robyn J Levy, Donald L McNeil, et al.
The Journal of Allergy and Clinical Immunology|August 10, 2010
The diagnosis and management of anaphylaxis practice parameter: 2010 updatePhillip Lieberman, Richard A Nicklas, John Oppenheimer, et al.
Pageof 2